| abstract |
Novel antigenic polypeptides comprising tumor-associated peptides and compositions comprising the same are provided. Such antigenic polypeptides and compositions are particularly useful as immunotherapeutic agents (eg, cancer vaccines). Methods of inducing a cellular immune response using the polypeptides and compositions, methods of treating diseases using the polypeptides and compositions, kits comprising the polypeptides and compositions, methods of making the compositions, and antibodies that specifically bind to the polypeptide and T cell receptors are also provided. |